Friday, December 16, 2011

Quotes for Christmas No. 4

"In 1910 a Danish botanist, Wilhelm Johannsen, self-consciously invented the word gene.  He was at pains to correct the common mythology and thought a word might help."



By James Gleick, The Information.

As of today a search on the word "gene" in Google Patents yields 40,700 results.  It looks like the word stuck.  I'm sure there will be more later on Tuesday.

Thursday, December 15, 2011

My Quotes for Christmas No.3

Thomas Edison Patent
398774 - 1883
"Meme - a unit of cultural inheritance ideas evolve like genes do and their success is based on their ability to spread not on the benefit they provide their host."

By Richard Dawkins, The Selfish-Gene 1976

I generally hate the light bulb metaphor for good ideas but I'll use it just this once because this image comes from the originator not from an art director.

Wednesday, December 14, 2011

Quotes of Christmas Round 2

"My view is that people are creative animals and will figure out cleaver ways to use tools that the inventor never imagined."

Steve Jobs as quoted in Steve Jobs by Walter Isaacson.

Who knows what will come about when you give an innovative object to an innovative human.



Tuesday, December 13, 2011

Twelve Quotes of Christmas

I am a patent nerd. There. I've said it. It's out. I'm also an information nerd. Where is it? How do you find it? What does it mean? How do you make it useful? So this holiday season I bring you the twelve quotes of Christmas. For the next 12 days I bring you my favorite quotes about patents, information, and how the two converge. So here we go.


"If the inventory of ready-made words in our language determines which concepts you are able to understand, how would you ever learn anything new?"

By Guy Deutscher, Honorary Research Fellow, School of Languages, Linguistics, and Cultures at the University of Manchester.

See my earlier post on this one here.


Monday, December 12, 2011

Licensing Molecules


Molecule - a group of atoms bonded together, representing the smallest fundamental unit of a chemical compound that can take part in a chemical reaction.

Licensing - a permit from an authority to own or use something, do a particular thing, or carry on a trade.

Cognitive Dissonance - a discomfort caused by holding conflicting ideas simultaneously - like licensing molecules.


This isn't a patentability debate it's just plain old cognitive dissonance on the headline.

(Reata Pharma has interesting patents with tons of non-patent prior art and lots of drawings of molecules. - It's probably easier to just license them than to try to read the patents.)



Sunday, December 11, 2011

Looking for Assignees - Again


USPTO has issued a Request for Information on enhanced reporting of assignee information on patent and patent application ownership. The need for improved patent assignee data is compelling. If you are manufacturing a product and you figure out that you need a license to a piece of technology, a daunting task by itself, you should be able to at least find the real entity and the real people associated with the entity to see if you can get the license you need. At present, this is a challenge.

Take it from me, trolling the Secretary of State sites, Pacer, and countless other data sources to see who owns Obfuscation Patent Holdings, LLC of Nevada and its various subsidiaries, shell companies, and owners of record is a tiring pursuit. It's entertaining at times when you hit the jackpot and can figure out who owns the mysterious patent that keeps showing up in the cease and desist letters. Usually it's fruitless because hiding ownership of a patent is one of the easiest things you can do at USPTO. It's time for more transparency in patent assignee data and USPTO has provided an opportunity to provide your input on the subject.

Send in your comments, encourage full disclosure.

Sunday, December 4, 2011

The patentability of medical tests that provide insight into how the human body reacts to disease and the drugs designed to treat them is a contentious issue. The test developers want patent protection on the inventions that they claim resulted in their specific discoveries. The medical and access to medicine constituencies believe that these tests are not patentable because they involve both abstract ideas and laws of nature.

Today's Wall Street Journal article provides an interesting overview of the issues, the players, and the upcoming Supreme Court cases.